1. O. Conterno and M. D. Turchi, “Antibiotics for treating chronic osteomyelitis in adults,” The Cochrane Database of Systematic Reviews, vol. 9, Article IDCD004439, 2013.
  2. D. P. Lewand P. F. A. Waldvogel, “Osteomyelitis,” The Lancet, vol. 364, no. 9431, pp. 369–379, 2004.
  3. Hogan, V. G. Heppert, and A. J. Suda, “Osteomyelitis,” Archives of Orthopaedic and Trauma Surgery, vol. 133, no. 9, pp. 1183–1196, 2013.
  4. C. B. Pollard, J. E. Newman,N. J.Barlow, J. D. Price, andK.M. Willett, “Deep wound infection after proximal femoral fracture: consequences and costs,” The Journal of Hospital Infection, vol. 63, no. 2, pp. 133–139, 2006.
  5. Trampuz and A. F. Widmer, “Infections associated with orthopedic implants,” Current Opinion in Infectious Diseases, vol. 19, no. 4, pp. 349–356, 2006.
  6. F. Widmer, “New developments in diagnosis and treatment of infection in orthopedic implants,” Clinical InfectiousDiseases, vol. 33, supplement 2, pp. S94–S106, 2001.
  7. Parsons and E. Strauss, “Surgical management of chronic osteomyelitis,” The American Journal of Surgery, vol. 188, no. 1, supplement 1, pp. 57–66, 2004.
  8. Geurts, J. J. Chris Arts, and G. H. I. M. Walenkamp, “Bone graft substitutes in active or suspected infection. Contraindicated or not?” Injury, vol. 42, supplement 2, pp. S82–S86, 2011.
  9. C. Corac¸a-Huber, M. Fille, J. Hausdorfer, D. Putzer, andM. Nogler, “Efficacy of antibacterial bioactive glass S53P4 against aureus biofilms grown on titanium discs in vitro,” Journal of Orthopaedic Research, vol. 32, no. 1, pp. 175–177, 2014.
  10. S. Kluin, H. C. van der Mei, H. J. Busscher, and D. Neut, “Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis,” Expert Opinion on Drug Delivery, vol. 10, no. 3, pp. 341–351, 2013.